FDA NDC Directory · JSON-LD · Markdown

Guaifenesin and Pseudoephedrine HCl

NDC 0536-1488 · HUMAN OTC DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerRUGBY LABORATORIES, INC.
Marketing categoryAbbreviated NDA (generic) · App ANDA212542
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsGUAIFENESIN (600 mg/1)
PSEUDOEPHEDRINE HYDROCHLORIDE (60 mg/1)
Marketing started20261012
Package count2

External sources

Source: openFDA. Public-domain (CC0).